MedTrace Logo

Influence of Probiotics on Atopy, Immunological Responses and Gut Microflora - Follow-up to 5 Years

NCT00365469 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 253

Last updated 2014-01-09

No results posted yet for this study

Summary

The investigators had conducted a double-blind, randomized placebo-controlled clinical trial studying the effects of 6 months probiotics supplementation from birth on allergic disease and sensitization up to 2 years of age. This follow-up study will extend a further 3 years to 5 years of age for assessing the longer term beneficial effects of this form of probiotics intervention on the incidence of allergic disease and sensitization at 5 years of age.

Conditions

Interventions

DIETARY_SUPPLEMENT

Probiotic

Bifidobacterium longum \[BL999\] and Lactobacillus rhamnosus \[LPR\]

OTHER

Placebo

Commercially available cow's milk based infant formula without probiotic supplementation

Sponsors & Collaborators

Principal Investigators

  • Dr Marion Aw, Consultant · National University Hospital, Singapore

  • Dr Lynette Shek, Consultant · National University Hospital, Singapore

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2011-09-30
Completion
2011-09-30

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00365469 on ClinicalTrials.gov